Renal Denervation: New Evidence Supporting Long-Term Efficacy, Alternative Access Routes, and Cost-Effectiveness.
作者信息
Wang Tzung-Dau
机构信息
Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan.
Smart Health Technology Research and Development Center, National Taiwan University, Taipei City, Taiwan.
出版信息
J Clin Hypertens (Greenwich). 2024 Dec;26(12):1528-1530. doi: 10.1111/jch.14945. Epub 2024 Nov 25.
Abstract
摘要
相似文献
1
Renal Denervation: New Evidence Supporting Long-Term Efficacy, Alternative Access Routes, and Cost-Effectiveness.
J Clin Hypertens (Greenwich). 2024 Dec;26(12):1528-1530. doi: 10.1111/jch.14945. Epub 2024 Nov 25.
2
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
Lancet. 2022 Oct 22;400(10361):1405-1416. doi: 10.1016/S0140-6736(22)01787-1. Epub 2022 Sep 18.
3
Effect of renal denervation on long-term outcomes in patients with resistant hypertension.
Cardiovasc Diabetol. 2021 Jun 5;20(1):117. doi: 10.1186/s12933-021-01309-3.
4
Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension.
J Am Coll Cardiol. 2012 Oct 2;60(14):1271-7. doi: 10.1016/j.jacc.2012.07.029. Epub 2012 Sep 12.
5
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial.
Lancet. 2021 Jun 26;397(10293):2476-2486. doi: 10.1016/S0140-6736(21)00788-1. Epub 2021 May 16.
6
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial.
Lancet. 2022 Apr 9;399(10333):1401-1410. doi: 10.1016/S0140-6736(22)00455-X. Epub 2022 Apr 4.
7
Renal denervation: unde venis et quo vadis?
Rofo. 2015 Apr;187(4):237-47. doi: 10.1055/s-0034-1385526. Epub 2015 Jan 28.
8
Ultra-long-term efficacy and safety of catheter-based renal denervation in resistant hypertension: 10-year follow-up outcomes.
Clin Res Cardiol. 2024 Oct;113(10):1384-1392. doi: 10.1007/s00392-024-02417-2. Epub 2024 Mar 7.
9
Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in Sweden.
Blood Press. 2025 Dec;34(1):2487583. doi: 10.1080/08037051.2025.2487583. Epub 2025 Apr 11.
10
Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in Canada.
J Med Econ. 2025 Dec;28(1):70-80. doi: 10.1080/13696998.2024.2441072. Epub 2024 Dec 19.
本文引用的文献
1
Catheter-Based Renal Denervation for Resistant Arterial Hypertension: 10-Year Real-World Follow-Up Data.
J Clin Hypertens (Greenwich). 2024 Dec;26(12):1521-1527. doi: 10.1111/jch.14931. Epub 2024 Nov 20.
2
Selecting Transfemoral Access or Upper Extremity Access for Renal Denervation Based on Vascular Morphology: Long-term Results.
J Clin Hypertens (Greenwich). 2024 Dec;26(12):1513-1520. doi: 10.1111/jch.14937. Epub 2024 Nov 17.
3
Cost-Effectiveness of Radiofrequency Renal Denervation for Uncontrolled Hypertension in Japan.
J Clin Hypertens (Greenwich). 2024 Dec;26(12):1502-1512. doi: 10.1111/jch.14922. Epub 2024 Nov 6.
4
The Netrod™ six-electrode radiofrequency renal denervation system for uncontrolled hypertension: a sham-controlled trial.
Eur Heart J. 2024 Nov 21;45(44):4761-4764. doi: 10.1093/eurheartj/ehae703.
5
Renal Denervation Lowers Nighttime Blood Pressure in True Resistant Hypertension.
Hypertension. 2024 Dec;81(12):e200-e202. doi: 10.1161/HYPERTENSIONAHA.124.23848. Epub 2024 Oct 21.
6
Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation in Chinese Patients With Uncontrolled Hypertension: The Randomized, Sham-Controlled, Multi-Center Iberis-HTN Trial.
Circulation. 2024 Nov 12;150(20):1588-1598. doi: 10.1161/CIRCULATIONAHA.124.069215. Epub 2024 Sep 4.
7
2024 ESC Guidelines for the management of elevated blood pressure and hypertension.
Eur Heart J. 2024 Oct 7;45(38):3912-4018. doi: 10.1093/eurheartj/ehae178.
8
SCAI Position Statement on Renal Denervation for Hypertension: Patient Selection, Operator Competence, Training and Techniques, and Organizational Recommendations.
J Soc Cardiovasc Angiogr Interv. 2023 Aug 21;2(6Part A):101121. doi: 10.1016/j.jscai.2023.101121. eCollection 2023 Nov-Dec.
9
Long-Term Blood Pressure Reductions Following Catheter-Based Renal Denervation: A Systematic Review and Meta-Analysis.
Hypertension. 2024 Jun;81(6):e63-e70. doi: 10.1161/HYPERTENSIONAHA.123.22314. Epub 2024 Mar 20.
10
Catheters in vascular interventional radiology: an illustrated review.
Diagn Interv Radiol. 2023 Jan 31;29(1):138-145. doi: 10.5152/dir.2022.21233. Epub 2022 Dec 28.
Zotero 插件